BSECompany Update6d ago · 14 Aug 2026, 06:50 pm
Intimation regarding Re-appointment of Manging Directors for the further term of five years pursuant to the approval of the Members at the 9th AGM of Amwill Health Care Limited.
Amwill Health Care Ltd · 544353
✦ AI SummaryMgmt Change
Amwill Health Care Ltd has announced the re-appointment of Mr. Tarun Gandhi and Mr. Anand Gandhi as Managing Directors for a further term of five years, effective from January 27, 2027.
Analysis Scores
Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Amwill Health Care Ltd - 544353 - Announcement under Regulation 30 (LODR)-Change in Management
Attachments (1)
📄pdf
Download →
1020ec8c-ee75-483f-9435-594e72d8847a.pdf
View document text
Date: August 14, 2026
The Bombay Stock Exchange
(BSE Limited)
Phiroze Jeejeebhoy Towers,
Dalal Street,
Mumbai- 400001
Scrip Name: AMWILL.
Company Scrip Code.: 544353
Re: Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations
and Disclosure Requirements) Regulations, ("SEBI Listing Regulations") read with SEBI Master Circular
no. (Ref: HO/49/14/14(7)2025-CFD-POD2/I/3762/2026) January 30, 2026 (“SEBI Master Circular”).
Subject: Intimation regarding Re-appointment of Managing Directors for a further term of five years
pursuant to approval of the Members at the 9th Annual General Meeting of Amwill Health Care Limited.
(“the Company”).
Dear Sir/Madam,
We wish to inform you that the Members of the Company, at the 09th Annual General Meeting (“9th AGM”) of
the Company held on today, August 14, 2026, had approved the re-appointment of the following Managing
Directors of the Company by way of special resolution, for a further term of five (5) years, with effect from
January 27, 2027, subject to the terms and conditions as approved by the Members:
1) Re-appointment of Mr. Tarun Gandhi (DIN: 07854699), as a Managing Director & Key Managerial
Personnel, on the recommendations of the Nomination,& Remuneration Committee and the Board of
Directors of the Company, for a period of consecutive 05 (five) years, commencing from January 27, 2027
till January 26, 2032.
2) Re-appointment of Mr. Anand Gandhi (DIN: 07854706), as a Managing Director & Key Managerial
Personnel, on the recommendations of the Nomination, & Remuneration Committee and the Board of
Directors of the Company, for a period of consecutive 05 (five) years, commencing from January 27, 2027
till January 26, 2032.
This disclosure is being made in compliance with Regulation 30 of the SEBI Listing Regulations and is
submitted for your information and record, will be available on the website of the Company
www.amwillhealthcare.com.
Thanking You.
FOR AMWILL HEALTH CARE LIMITED
Anshu Anshuman
Company Secretary and Compliance Officer
ACS65515
Address: No. 90, 4th Floor, 2nd Main Road, 7th Cross,
Chamrajpet, Bangalore - 560018, Karnataka
Place: Bangalore
Annexure A
Details with respect to Change in Key Managerial Personnel (Resignation and appointment of director) under
Regulation 30 read with Part A of Schedule III of the Listing Regulations, read with SEBI Master Circular no.
(Ref: HO/49/14/14(7)2025-CFD-POD2/I/3762/2026) January 30, 2026 (“SEBI Master Circular”), and other
applicable circulars/guidelines issued by SEBI from time to time.
S.N. Particulars Mr. Tarun Gandhi (DIN: Mr. Anand Gandhi (DIN:
07854699) as Managing Director 07854706) as Managing Director
1 Reason for Change Re-appointment Re-appointment
viz.
appointment,
resignation, removal,
death or otherwise.
2 Date of appointment/ Date of re-appointment as Date of re-appointment as
reappointment/ Managing Director: January 26, Managing Director: January 26,
cessation 2027 2027
(as applicable)
3 Term of appointment/ Mr. Tarun Gandhi (DIN: Mr. Anand Gandhi (DIN:
reappointment 07854699) as Managing Director 07854706) as Managing Director
shall be reappointed as a shall be reappointed as a
Managing Director, to not liable to Managing Director, to not liable to
retire by rotation and a Key retire by rotation and a Key
Managerial Personnel, for a period Managerial Personnel, for a period
of 05 (five) consecutive years of 05 (five) consecutive years
commencing from January 27, commencing from January 27,
2027 till January 26, 2032. 2027 till January 26, 2032.
Detailed terms of re-appointment Detailed terms of re-appointment
and maximum remuneration and maximum remuneration
payable to Mr. Tarun Gandhi as payable to Mr. Anand Gandhi (as
Managing Director, shall be Managing Director, shall be
referred from the Notice referred from the Notice
convening 09th AGM. convening 09th AGM.
4 Brief profile (in case Provided below Provided below
of appointment)
5 Relation with Relative of Mr. Anand Gandhi Relative of Mr. Tarun Gandhi
directors of company
(in case of
appointment)
6 Information as Mr. Tarun Gandhi (DIN: Mr. Anand Gandhi (DIN:
required pursuant to 07854699) is not debarred from 07854706) is not debarred from
BSE Circular No. holding the office of Director by holding the office of Director by
LIST/COMP/14/2018- virtue of any SEBI order or any virtue of any SEBI order or any
19 and NSE Circular other such authority. other such authority.
No. NSE/
CML/2018/24 dated
June 20, 2018.
Brief Profile
Mr. Tarun Gandhi (DIN: 07854699) as Managing Mr. Anand Gandhi (DIN: 07854706) as Managing
Director Director
Mr. Tarun Gandhi holds a bachelor’s degree in Mr. Anand Gandhi holds a bachelor’s and master’s
commerce (advanced financial accounting and degree in pharmacy (pharmaceutics) with honours from
management accounting) with honors from Bangalore Rajiv Gandhi University of Health Sciences, Karnataka.
University.
Mr. Anand Gandhi holds experience of more than a
Mr. Tarun Gandhi holds experience of more than a decade in brand placement, marketing and sales and
decade in financial management, accounts management enhancing product visibility in the dermatology segment
and business development. Hence, meets all such of the pharmaceutical industry. Hence, meets all such
requirements for this role. requirements for this role